You are here
Roche says 2017 profit growth unlikely to outstrip sales
ROCHE on Wednesday forecast that profit growth would not outstrip sales in 2017 as the world's top cancer drugmaker increases spending on new products that it hopes will offset declines in ageing biotech medicines now going off patent.
The Swiss drugmaker dismissed
CALL +65 6388 3838 EMAIL firstname.lastname@example.org